BPAMU
ABBV icon

BTG Pactual Asset Management US’s AbbVie ABBV Stock Holding History

BTG Pactual Asset Management US’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-600
Closed -$111K – 249
2025
Q2 		$111K Buy
+600
New +$112K 0.01% 199

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BTG Pactual Asset Management US's ABBV Position: Q1 2026 in Review

BTG Pactual Asset Management US increased its AbbVie (ABBV) stake by 24% in Q1 2026, buying an estimated $1.24M and bringing the position to 28,476 shares worth $6.19M. The position accounts for 0.54% of the portfolio, ranked #55.

BTG Pactual Asset Management US first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. 4,088 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • BTG Pactual Asset Management US held 28,476 shares of AbbVie worth $6.19M as of Q1 2026.
  • BTG Pactual Asset Management US bought 5,598 AbbVie shares in Q1 2026, an estimated $1.24M.
  • AbbVie made up 0.54% of BTG Pactual Asset Management US's portfolio in Q1 2026, its #55 holding.
  • BTG Pactual Asset Management US first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • 4,088 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on BTG Pactual Asset Management US's 13F filing for Q1 2026, filed 14 May 2026.